Page 7 - Johnson & Johnson

S P Jain Global bags 50% international offers, top offer at Rs 45 lakh

Consulting emerges as top recruiting sector, with 24% placement offers, followed by logistics & supply chain at 17%, and IT at 16%

J&J's own expert working for FDA found asbestos in baby powder sample

(Reuters) - Ever since Johnson & Johnson disclosed this month that a government test had turned up asbestos in its Baby Powder, the company has attacked the validity of the result.

Johnson & Johnson to expand its anti-TB programme in India

Programme aims to broaden access to treatment for multidrug-resistant strain, improve detection, build critical health systems, and raise awareness about TB at community level

J&J asked to pay $8 billion over side effects of antipsychotic drug

NEW YORK (Reuters) - Johnson & Johnson must pay $8 billion (6.6 billion pounds) in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.

US judge fines Johnson & Johnson $572 mn for fuelling opioid epidemic

(Reuters) - An Oklahoma judge on Monday found Johnson & Johnson liable for fuelling an opioid epidemic in the state by deceptively marketing painkillers, and ordered the drugmaker to pay damages of $572 million.

J&J pays Rs 25 lakh each to three victims in UP for faulty hip implants

Pharmaceutical Major Johnson & Johnson said it has paid Rs 25 lakh each to three victims of its faulty acetabular surface replacement (ASR) hip implants in Uttar Pradesh. According to Uttar Pradesh Drug Licensing and Control officer A K Jain, the company has given compensation to three patients who had undergone revision surgeries for the faulty implants made by the company. The Delhi High Court had in May directed Johnson and Johnson to make an interim payment of Rs 25 lakh each to the 67 patients who have undergone revision surgeries. Jain said the Uttar Pradesh Drug Licensing and Control Authority was promptly following such complaints.

J&J denies withholding interim compensation for faulty hip implants

However, the central government told the court that the company till date has paid the interim compensation to only 67 patients out of the over 4,700 persons

J&J to pay Rs 25 lakh each to 67 victims of faulty ASR hip implants

J&J says it will pay other patients only if they fulfil criteria set by company

J&J's largest India plant idle for 3 yrs, hurts govt's employment campaign

The groundbreaking of the J&J facility in Telangana's Penjerla, its third in the country, was carried out with much fanfare in 2014.

No formaldehyde in baby shampoo: J&J rejects Rajasthan govt report

Johnson & Johnson has strongly rejected findings of a Rajasthan government laboratory showing presence of "harmful" chemicals in the US-based company's baby shampoo, a popular product in India. Based on the report of the Drug Testing Laboratory in Jaipur, the National Commission for Protection of Child Rights (NCPCR) has written to the chief secretaries of all states and Union Territories asking them to stop sale of Johnson & Johnson's (J&J) baby shampoo and remove it from the stocks. The NCPCR said the test report found presence of formaldehyde in J&J's baby shampoo. The company, in a statement, said it has not received any direction to stop the sale of its shampoo and that it was not accepting the interim results of the laboratory tests which were based on "unknown and unspecified" methods. India is a major market for J&J globally, and its share in the country's Rs 4,000-crore baby care market is nearly three-fourths. "We will await the results and conclusions of

Child rights body asks states to stop sale of Johnson's baby shampoo

Its sample was found to be of substandard quality in a lab test

J&J tries to use supplier bankruptcy to fight 2,400 baby-powder lawsuits

J&J is facing more than 14,000 claims its talc products caused ovarian cancer or mesothelioma, a rare cancer linked to asbestos exposure. The company denies its products ever contained the carcinogen

J&J moves Delhi HC, says willing to pay only Rs 25 lakh to victims

The company said it was willing to pay Rs 25 lakh as compensation to those affected but could not agree to the arbitrary amounts being imposed by the government

Johnson & Johnson wins trial over California man's talc-cancer claims

J&J is facing more than 13,000 lawsuits linking baby powder and another talc product

Does J&J's 'No More Tears' baby shampoo contain cancer-causing substance?

Rajasthan's drug controller found that Johnson & Johnson baby shampoo samples were not of standard quality

J&J's baby shampoo samples are not of standard quality: Drug controller

This comes after J&J's hip implants and baby powder were declared defective

Govt order asking J&J to pay compensation is complete hogwash: Expert

In November, the government had come up with a compensation formula based on factors such as age, risk and percentage of disability

US court awards $29 mn to cancer victim who alleged J&J talcum had asbestos

(Reuters) - A California jury on Wednesday awarded $29 million to a woman who said that asbestos in Johnson & Johnson's talcum-powder-based products caused her cancer.

J&J asked to pay Rs 74.5 lakh to first patient with faulty hip implant

Based on the recommendations of the central expert committee and the state-level committee, the Central Drugs Standard Control Organisation (CDSCO) has directed Johnson and Johnson to pay Rs 74,57,180 to the first patient from Mumbai who received faulty hip implants made by the company. This is the first case where M/s Johnson & Johnson has been directed to pay compensation for its faulty ASR hip implants manufactured and imported by M/s DePuy International Limited (now Johnson & Johnson Pvt Ltd). The CDSCO has directed the compensation to be paid within 30 days from the date of receipt of the order. In November last year, the Union Health Ministry approved a formula for determination of compensation for patients who had received, prior to August 2010, ASR hip implants manufactured by DePuy International Limited, U.K of J&J. According to the formula, thousands of patients implanted with US pharmaceutical major Johnson and Johnson's (J&J) articular surface replacement ..

Govt directs J&J to pay Rs 74 lakh to first victim of faulty hip implant

The expert committee had earlier suggested that patients should be paid based on the disability caused